WO2012011917A1 - Administration of rifalazil to immunocompromised patients - Google Patents

Administration of rifalazil to immunocompromised patients Download PDF

Info

Publication number
WO2012011917A1
WO2012011917A1 PCT/US2010/043003 US2010043003W WO2012011917A1 WO 2012011917 A1 WO2012011917 A1 WO 2012011917A1 US 2010043003 W US2010043003 W US 2010043003W WO 2012011917 A1 WO2012011917 A1 WO 2012011917A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
rifalazil
treating
infection
cyp450
Prior art date
Application number
PCT/US2010/043003
Other languages
French (fr)
Inventor
Chalom Sayada
Original Assignee
Activbiotics Pharma, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activbiotics Pharma, Llc filed Critical Activbiotics Pharma, Llc
Priority to PCT/US2010/043003 priority Critical patent/WO2012011917A1/en
Publication of WO2012011917A1 publication Critical patent/WO2012011917A1/en

Links